About

Sheela Ranganathan is an associate in the Corporate Practice Group in the firm's Washington, D.C. office and a member of the firm’s Healthcare Team.

Latest Post

The Inflation Reduction Act (the “IRA”) requires drug manufacturers to pay rebates to Medicare when the prices of their Part B and Part D prescription drug increase faster than the rate of inflation. We recently discussed the guidance documents issued by the Centers for Medicare and Medicaid Services (“CMS”) detailing the proposed implementation of the Medicare Part B and Medicare Part D Prescription Drug Inflation Rebate Programs.

Continue Reading CMS Releases First Set of Part B Rebatable Drugs for Coinsurance Adjustment Under IRA

About

Sheela Ranganathan is an associate in the Corporate Practice Group in the firm's Washington, D.C. office and a member of the firm’s Healthcare Team.

Subscribe: Subscribe via RSS